Pain – NSAIDS

  • Caldolor 2017 report

    Caldolor 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Duexis 2017 report

    Duexis 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 34 Pages The 5 Key Questions Addressed by this Report:...

  • Dyloject 2017 report

    Dyloject 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Flector Patch 2017 report

    Flector Patch 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this...

  • Ofirmev 2017 report

    Ofirmev 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Pennsaid 2017 report

    Pennsaid 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 30 Pages The 5 Key Questions Addressed by this Report:...

  • Sprix 2017 report

    Sprix 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 34 Pages The 5 Key Questions Addressed by this Report:...

  • Tivorbex 2017 report

    Tivorbex 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Vivlodex 2017 report

    Vivlodex 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Zipsor 2017 report

    Zipsor 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Zorvolex 2017 report

    Zorvolex 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Caldolor 2016 report

    Caldolor 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 28 Pages The 5 Key Questions Addressed by this Report:...